Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Maciejewski

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 9, 2000
Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicityK Skladowski, B Maciejewski, M Golen, et al.
Nowotwory|April 1, 1989
[Radiotherapy of tonsillar cancer. II. Tumor repopulation and normal tissue tolerance]B Maciejewski, H R Withers, J M Taylor, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2013
Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancerT Rutkowski, A Wygoda, K Składowski, et al.
The British Journal of Radiology|July 17, 2014
Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trialL Miszczyk, B Maciejewski, A Tukiendorf, et al.
Neoplasma|January 1, 1991
Hyperfractionated radiotherapy for Burkitt-type lymphoma. Radiobiological aspectsB Pilecki, P Kopiec, A Zajusz, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 26, 2011
Predictors of radiotherapy outcome in patients with T2 supraglottic carcinomaTomasz Rutkowski, A Wygoda, K Składowski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1991
Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancerB Maciejewski, A Zajusz, B Pilecki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1996
Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicityB Maciejewski, K Skladowski, B Pilecki, et al.
Otolaryngologia Polska = the Polish Otolaryngology|January 1, 1996
[Prognostic factors in radiotherapy of supraglottic cancer]K Składowski, A Zajusz, J Swiatnicka, et al.
European Journal of Radiology|July 13, 1999
Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patientsJ Walecki, M Sokól, P Pieniazek, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 9, 2000
Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicityK Skladowski, B Maciejewski, M Golen, et al.
Nowotwory|April 1, 1989
[Radiotherapy of tonsillar cancer. II. Tumor repopulation and normal tissue tolerance]B Maciejewski, H R Withers, J M Taylor, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2013
Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancerT Rutkowski, A Wygoda, K Składowski, et al.
The British Journal of Radiology|July 17, 2014
Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trialL Miszczyk, B Maciejewski, A Tukiendorf, et al.
Neoplasma|January 1, 1991
Hyperfractionated radiotherapy for Burkitt-type lymphoma. Radiobiological aspectsB Pilecki, P Kopiec, A Zajusz, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 26, 2011
Predictors of radiotherapy outcome in patients with T2 supraglottic carcinomaTomasz Rutkowski, A Wygoda, K Składowski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1991
Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancerB Maciejewski, A Zajusz, B Pilecki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1996
Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicityB Maciejewski, K Skladowski, B Pilecki, et al.
Otolaryngologia Polska = the Polish Otolaryngology|January 1, 1996
[Prognostic factors in radiotherapy of supraglottic cancer]K Składowski, A Zajusz, J Swiatnicka, et al.
European Journal of Radiology|July 13, 1999
Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patientsJ Walecki, M Sokól, P Pieniazek, et al.
Pageof 7